Transduced Tat-Annexin protein suppresses inflammation-associated gene expression in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells
- Authors
- Lee, Sun Hwa; Kim, Dae Won; Back, Su Sun; Hwang, Hyun Sook; Park, Eun Young; Kang, Tae-Cheon; Kwon, Oh-Shin; Park, Jong Hoon; Cho, Sung-Woo; Han, Kyu Hyung; Park, Jinseu; Eum, Won Sik; Choi, Soo Young
- Issue Date
- Jul-2011
- Publisher
- KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
- Keywords
- Cytokine; Inflammation; MAPK; Protein therapy; Tat-ANX1
- Citation
- BMB REPORTS, v.44, no.7, pp.484 - 489
- Journal Title
- BMB REPORTS
- Volume
- 44
- Number
- 7
- Start Page
- 484
- End Page
- 489
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/12532
- DOI
- 10.5483/BMBRep.2011.44.7.484
- ISSN
- 1976-6696
- Abstract
- Annexin-1 (ANX1) is an anti-inflammatory protein as well as an important modulator in inflammation. However, the precise action of ANX1 remains unclear. To elucidate the protective effects of ANX1 on lipopolysaccharide (LPS)-induced murine macrophage Raw 264.7 cells, we constructed a cell-permeable Tat-ANX1 protein. The transduced Tat-ANX1 protein markedly inhibited the expression of cyclooxygenase-2, production of prostaglandin E-2, and generation of pro-inflammatory cytokines in the cells. Furthermore, transduced Tat-ANX1 protein caused a significant reduction in the activation of nuclear factor-kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK). The results indicate that Tat-ANX1 inhibits the production of inflammatory response cytokines and enzymes by blocking NF-kappa B and MAPK. Therefore, Tat-ANX1 protein may be useful as a therapeutic agent against various inflammatory diseases. [BMB reports 2011; 44(7): 484-489]
- Files in This Item
-
Go to Link
- Appears in
Collections - 이과대학 > 생명시스템학부 > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.